-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

114.O1.6 114. Hemoglobinopathies, Excluding Thalassemia: Clinical and Epidemiological: Novel Therapies

Symposia: Hemoglobinopathies, Excluding Thalassemia: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, Sickle Cell Disease, clinical trials, adult, Non-Biological therapies, Translational Research, Clinical Research, Hemoglobinopathies, drug development, Diseases, Gene Therapy, Therapies, Adverse Events, metabolism, Biological Processes, Technology and Procedures, Study Population, Human, omics technologies
Saturday, December 10, 2022: 9:30 AM-11:00 AM
391-392 (Ernest N. Morial Convention Center)
Moderator:
and Kleber Yotsumoto Fertrin, MD, PhD, University of Washington
Disclosures:
Fertrin: Sanofi Genzyme: Consultancy; Agios Pharmaceuticals: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau; Global Blood Therapeutics: Consultancy, Speakers Bureau.
This session will describe research and updated results of novel therapies for sickle cell disease.
9:30 AM

Claudia R. Morris, MD1,2, Nitya Bakshi, MBBS, MS3, Deborah Leake, CPNP4*, Scott Gillespie, MS5*, Lou Ann Scism Brown, PhD6*, Frank Harris6*, Kirshma Khemani, MD7*, Alexus Locke, MS8*, Christopher A Rees, MD, MPH9*, Mark A Griffiths, MD10*, Loretta Reyes, MD11*, Polly Kumari, MBBS12*, Sruti Shiva, PhD13 and Carlton D. Dampier, MD2,14,15,16

1Childrens Healthcare of Atlanta, Atlanta, GA
2Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
3Department of Pediatrics/Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA
4Pediatric Emergency Medicine, Children's Healthcare of/Emory University School of Medicine, Atlanta, GA
5Pediatric Biostatics Core, Emory University, Atlanta, GA
6Emory University School of Medicine, Atlanta, GA
7Department of Pediatrics, Division of Hematology/Oncology/BMT, Emory University School of Medicine, Atlanta, GA
8Emergency Medicine, Children’s Healthcare of Atlanta/Egleston Hospital, Atlanta, GA
9Pediatrics, Emory University School of Medicine, Atlanta, GA
10Emory University School of Medicine/Pediatric Emergency Medicine, Children’s Healthcare of Atlanta, Hughes Spalding, Atlanta, GA
11Division of Pediatric Nephrology, Emory University School of Medicine/Children's Healthcare of Atlanta, Atlanta, GA
12Pediatrics Emergency Medicine, Emory University School of Medicine, Atlanta, GA
13Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA
14Emory University, Atlanta, GA
15Aflac Cancer and Blood Disorders Center, Atlanta, GA
16Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Atlanta, GA

9:45 AM

Philippe Joly1,2*, Elie Nader3*, Flora Ketels4*, Camille Boisson5*, Romain Carin6*, Celine Renoux, PhD5,7*, Alexandra Gauthier8*, Solène Poutrel9*, Yves Bertrand, PhD10* and Philippe Connes, PhD11*

1Groupement Hospitalier Est, Hospices Civils de Lyon, BRON, AL, France
2Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) - EA 7424, Université Claude-Bernard Lyon 1, Lyon, France
3Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) - EA7424, Université Claude-Bernard Lyon 1, LYON, France
4Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) - EA 7424, Université Calude-Bernard Lyon 1, LYON, France
5Laboratory LIBM EA7424, University of Lyon 1, “Vascular Biology and Red Blood Cell” team, Lyon, France
6Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) - EA 7424, Université Claude-Bernard Lyon 1, LYON, France
7Laboratory of Biochemistry and Molecular Biology, UF Biochemistry of Red Blood Cell diseases, Est Center of Biology and Pathology, Hospices Civils de Lyon, Lyon, France
8Institut d'Hématologie et d'Oncologie Pédiatrique (IHOP), LYON, France
9Hôpital Edouard-Herriot - Service de Médecine Interne, Hospices Civils de Lyon, LYON, France
10Institut d`Hematologie et d`Oncologie Pediatrique,Unité de coordination interne et externe, Lyon, France
11Laboratoire LIBM EA7424 – Equipe « Biologie Vasculaire et du Globule Rouge », Université Claude Bernard Lyon 1, LYON, France

10:00 AM

Myrthe J. van Dijk1,2*, Sigrid van der Veen2*, Minke A.E. Rab, MD, PhD1,3*, Brigitte A. van Oirschot1*, Jennifer Bos1*, Cleo Derichs2*, Anita W. Rijneveld, MD, PhD4*, Marjon H. Cnossen5*, Erfan Nur, MD, PhD6,7, Bart J Biemond8, Marije Bartels2*, Judith J.M. Jans9*, Richard van Wijk1* and Eduard J. Van Beers, MD, PhD2*

1Central Diagnostic Laboratory - Research, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
2Center for Benign Hematology, Thrombosis and Hemostasis - Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
3Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
4Erasmus University Medical Center Cancer Institute, Rotterdam, Netherlands
5Department of Pediatric Hematology, Erasmus MC Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, Netherlands
6Department of Blood Cell Research, Sanquin Research, Amsterdam, Netherlands
7Department of Hematology, Amsterdam University Medical Center, Amsterdam, Netherlands
8Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
9Section Metabolic Diagnostics, Department of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands

10:15 AM

Modupe Idowu, MD1, Thinh Nguyen, MD2*, Derek Lewis, MD3*, Thokozeni Lipato, MD4*, Erin M. Buckley, PhD5*, Rowan Brothers, BS6*, Mariam Akbar, BS7*, Sydney Triplett, BS7*, Kobina Dufu, PhD8* and Eleanor Lisbon, MD, MPH8*

1University of Texas McGovern Medical School, Houston, TX
2Visionaries Clinical Research, Atlanta, GA
3Arkansas Primary Care Clinic, Little Rock, AR
4Virginia Commonwealth University Health, Richmond, VA
5Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
6Emory University, Atlanta, GA
7Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA
8Global Blood Therapeutics, South San Francisco, CA

10:30 AM

Mark C. Walters, MD1, Alexis A. Thompson, MD, MPH2,3, Janet L. Kwiatkowski, MD, MSCE4,5, Suhag Parikh, MD6*, Markus Y. Mapara, MD, PhD7, Stacey Rifkin-Zenenberg, DO8, Banu Aygun, MD9, Kimberly A. Kasow, DO10*, Alex Miller, BS11*, Lixin Zhang, PhD11*, Anjulika Chawla, MD11*, Elizabeth R. Macari, PhD11*, Francis J. Pierciey Jr., MSc11*, John F. Tisdale, MD12* and Julie Kanter, MD13

1UCSF Benioff Children's Hospital, Oakland, CA
2Northwestern University Feinberg School of Medicine, Chicago, IL
3Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
4Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
5Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA
6Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University, Atlanta, GA
7Division of Hematology/Oncology, Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY
8Hackensack University Medical Center, Hackensack, NJ
9Cohen Children’s Medical Center, New Hyde Park, NY
10University of North Carolina, Chapel Hill, NC
11bluebird bio, Inc., Somerville, MA
12Cellular and Molecular Therapeutics Branch NHLBI/NIDDK, National Institutes of Health, Bethesda, MD
13University of Alabama Birmingham, Birmingham, AL

10:45 AM

Haydar Frangoul, MD1, Franco Locatelli, MD2, Monica Bhatia, MD3*, Markus Y. Mapara, MD, PhD4, Lyndsay Molinari, MD5*, Akshay Sharma, MBBS6, Stephan Lobitz, MD7*, Mariane de Montalembert, MD, PhD8, Damiano Rondelli, MD9, Martin Steinberg, MD10, Mark C. Walters, MD11, Suzan Imren, MD12*, Lanju Zhang, PhD12*, Anjali Sharma, MD13*, Yang Song, PhD12*, Christopher Simard, MD12*, William Hobbs, MD, PhD12* and Stephen Grupp, MD14*

1Sarah Cannon Center Research Institute and The Children’s Hospital at TriStar Centennial, Nashville, TN
2Department of Pediatric Hematology and Oncology, Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Italy
3Department of Pediatrics, Columbia University, NewYork-Presbyterian Morgan Stanley Children’s Hospital, New York, NY
4Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
5Sarah Cannon Pediatric Transplant and Cellular Therapy Program at Methodist Children’s Hospital, San Antonio, TX
6Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital, Memphis, TN
7Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany
8Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), University of Paris, Paris, France
9University of Illinois at Chicago, Chicago, IL
10Boston University School of Medicine, Boston, MA
11University of California San Francisco Benioff Children’s Hospital, Oakland, CA
12Vertex Pharmaceuticals Incorporated, Boston, MA
13CRISPR Therapeutics, Cambridge, MA
14Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

*signifies non-member of ASH